Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...

A Wilmington manufacturing plant will receive millions as part of a company's $1 billion commitment to enhance manufacturing sites nationwide.

The investment in Durham is part of a $100 million commitment across the company's entire North Carolina operation that also ...

House Republicans’ funding patch includes cutting funds for the Congressionally Directed Medical Research Programs, an agency ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

Merck has launched a $1 billion vaccine manufacturing facility in Durham, North Carolina, as part of a $12 billion U.S.

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...